The pyroptotic role of Caspase-3/GSDME signalling pathway among various cancer: A Review

AA Bhat, R Thapa, O Afzal, N Agrawal… - International journal of …, 2023 - Elsevier
Cytotoxic drugs have long been recognised to kill cancer cells through apoptosis. According
to a current study, pyroptosis inhibits cell proliferation and shrinks tumors. Pyroptosis and …

[HTML][HTML] Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis

V Salvestrini, K Kim, S Caini, S Alkner, M Ekholm… - Radiotherapy and …, 2023 - Elsevier
Abstract Background and Purpose In recent years, the treatment landscape for breast cancer
has undergone significant advancements, with the introduction of several new anticancer …

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆

S Loibl, F André, T Bachelot, CH Barrios… - Annals of …, 2024 - annalsofoncology.org
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
- Annals of Oncology Skip to Main Content Advertisement Annals of Oncology European …

[HTML][HTML] Understanding breast cancer complexity to improve patient outcomes: the St Gallen international consensus conference for the primary therapy of individuals …

G Curigliano, HJ Burstein, M Gnant, S Loibl… - Annals of …, 2023 - Elsevier
The 18th St Gallen International Breast Cancer Conference held in March 2023, in Vienna,
Austria, assessed significant new findings for local and systemic therapies for early breast …

Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open …

BH Chua, EK Link, IH Kunkler, TJ Whelan… - The Lancet, 2022 - thelancet.com
Background Whole breast irradiation (WBI) after conservative surgery for ductal carcinoma
in situ (DCIS) reduces local recurrence. We investigated whether a tumour bed boost after …

Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10 …

V Strnad, C Polgár, OJ Ott, G Hildebrandt… - The Lancet …, 2023 - thelancet.com
Background Several randomised, phase 3 trials have investigated the value of different
techniques of accelerated partial breast irradiation (APBI) for patients with early breast …

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised …

CE Coles, JS Haviland, AM Kirby, CL Griffin… - The Lancet, 2023 - thelancet.com
Background A tumour-bed boost delivered after whole-breast radiotherapy increases local
cancer-control rates but requires more patient visits and can increase breast hardness …

Partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ: an ASTRO clinical practice guideline

SF Shaitelman, BM Anderson, DW Arthur… - Practical radiation …, 2024 - Elsevier
Purpose This guideline provides evidence-based recommendations on appropriate
indications and techniques for partial breast irradiation (PBI) for patients with early-stage …

Partial breast irradiation versus whole breast irradiation for early breast cancer patients in a randomized phase III trial: the Danish breast cancer group partial breast …

BV Offersen, J Alsner, HM Nielsen… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE On the basis of low risk of local recurrence in elderly patients with breast cancer
after conservative surgery followed by whole breast irradiation (WBI), the Danish Breast …

St. Gallen/Vienna 2023: Optimization of treatment for patients with primary breast cancer–A brief summary of the consensus discussion

M Balic, C Thomssen, M Gnant, N Harbeck - Breast Care, 2023 - karger.com
Abstract The St. Gallen Consensus Conference on early breast cancer treatment 2023 was
again a live event and took place in Vienna, Austria. After 4 years and one virtual event due …